Comprehensive Tobacco Cessation for Cancer Patients and Survivors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Behavioral counseling for tobacco cessation.
- Who it may be relevant to
- Registry conditions: Tobacco Use Cessation, Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Building a Comprehensive Tobacco Cessation Program for Cancer Patients and Survivors: "A Breath of Fresh Air"
Overview
The purpose of this research study is to learn how best to incorporate tobacco cessation treatment into clinical care for cancer patients, survivors, and caregivers.
Detailed description
The goal of this study is to generate knowledge regarding the feasibility and acceptability of integrating tobacco cessation treatment into clinical care for cancer patients, survivors, and caregivers. The evidence base regarding tobacco treatment is solid: pharmacology (nicotine replacement therapy (and/or), bupropion, or varenicline) in combination with behavioral counseling yields the best results with respect to cessation rates. What remains unclear is how best to offer and implement this comprehensive treatment in the context of a cancer center-especially in a patient population facing social determinants of health that may not be in favor of tobacco cessation. Thus, in this study, the investigators are offering the "gold standard" tobacco treatment and assessing feasibility and acceptability of these procedures in order to inform future efforts to optimize treatment delivery for this unique population and setting. The intervention for this protocol was approved for standard of care use.
Interventions
- Behavioral Behavioral counseling for tobacco cessation
Participants can choose to receive behavioral counseling in group v. individual format: Group Sessions: Participants will be offered the opportunity to attend 6 weekly 60-90 minute sessions Individual Sessions: Participants will be offered the opportunity to attend up to 12 30-45 minute sessions on a schedule mutually agreed upon between interventionist and participant
Primary outcome measures
- Feasibility: Consent rate [Time frame: At enrollment visit]
- Feasibility: Barriers to participation [Time frame: At recruitment visit]
- Acceptability: Participant satisfaction [Time frame: Week 6]
- Acceptability: Participant satisfaction [Time frame: Week 12]
- Acceptability: Participant satisfaction [Time frame: Week 24]
- Acceptability: Behavioral counseling attendance [Time frame: 12 weeks]
- Acceptability: Nicotine replacement therapy adherence [Time frame: Week 6]
- Acceptability: Nicotine replacement therapy adherence [Time frame: Week 12]
- Acceptability: Nicotine replacement therapy adherence [Time frame: Week 24]
Eligibility criteria
Inclusion criteria
- Provision of signed and dated informed consent form
- Stated willingness to comply with study procedures and availability for the duration of the study
- Have a documented history of cancer of any type, whether active or in remission
- Identify as a current or recently-quit tobacco user
Exclusion criteria
- Not a VCUHealth patient
- Non English-speaking
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Virginia Commonwealth University — Richmond
Identifiers
NCT: NCT05805722 · MCC-22-19970 · HM20026004